Abstract
Valvular heart disease is a growing field, and the number of new approaches for percutaneous treatment is increasing rapidly. These procedures usually cannot be performed with fluoroscopy alone; allowing echocardiography to be an essential role inside the Cath Lab. Three-dimensional echocardiography, and the introduction of a novel imaging modality that integrates live echocardiography and live fluoroscopy imaging, has potential in facilitating procedure guidance and increasing procedure efficiency.
Please view the full content in the pdf above.
